Disruption of Stromal-Derived Factor-1/Chemokine Receptor 4 by Simvastatin

M  Masori; A  Jalili; Y  Nakaya

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards & Committees Indexing and Listing Sources Journal Metrics Publication Ethics and Publication Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Disruption of Stromal-Derived Factor-1/Chemokine Receptor 4 by Simvastatin

Author(s):

M Masori,

A Jalili^,*,

Y Nakaya

International Cardiovascular Research Journal:Vol. 4, issue 1; e67617

Published online:Mar 31, 2010

Article type:Research Article

Received:Feb 16, 2010

Accepted:Mar 30, 2010

How to Cite:M MasoriA JaliliY NakayaDisruption of Stromal-Derived Factor-1/Chemokine Receptor 4 by Simvastatin.Int Cardiovasc Res J.4(1):e67617.

Abstract

Background: The alpha chemokine, stromal-derived factor (SDF)-1 is produced by bone marrow stromal cells
and other cells, especially damaged tissues. SDF-1 receptor, a chemokine receptor 4 (CXCR4), is expressed
on inflammatory cells and that SDF-1/CXCR4 axis plays a critical role in migration of inflammatory cells. In
cardiovascular diseases, SDF-1 is produced by endothelial cells and plaques and that SDF-1 chemoattracts
monocytes to the endothelial cells resulting in a local inflammation. Simvastatin, a cholesterol-lowering agent,
is a general drug for treatment of cardiovascular diseases. However, its molecular mechanism has not yet been
completely elucidated.
Method: Herein, we investigated the role of simvastatin on the SDF- 1/CXCR4 axis by employing flow cytometry,
RT-PCR, chemotaxis and adhesion assays.
Results: Simvastatin (i) downregulates CXCR4 expression on monocytic cell line (THP-1) and primary monocyte
in a dose-dependent manner, (ii) inhibits adhesion of monocytes to endothelial cells and (iii) decreases
SDF-1 production by endothelial cells. Moreover, preincubation with simvastatin significantly decreased the
migration of THP-1 towards the SDF-1 gradient.
Conclusion: All together our data indicate that simvastatin inhibits the binding of monocytes to endothelial cells
through disrupting of the SDF-1/CXCR4 axis.

Keywords

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

comments